The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments. Kole Roybal, PhD | Director Lawrence Fong, MD | Co-Director All Investigators Related Press Release PICI, JDRF and Helmsley Trust Form Research Initiative Announcement PICI Young Investigator Retreat 2019 Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators Announcement Behind the Breakthrough: An Interview with Carl June, the Father of CAR T-Cell Therapy Announcement PICI Network Investigators to Showcase Immunotherapy Advances at ASCO 2024 Announcement Unlocking Complex Cell-based Gene Therapies: A Joint Workshop Hosted by PICI and FOCR Announcement PICI Hosts 2024 Spring Scientific Retreat
Announcement, Press Release Parker Institute Welcomes New Co-Directors for PICI Centers at Stanford, UCSF & Penn
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators